Venous thromboembolism (VTE) has emerged as an important issue in patients with COVID-
19. The purpose of this study is to identify the incidence of VTE and mortality in COVID-19 …

Background: The coronavirus disease 2019 (COVID-19) is a newly recognized illness that
has spread rapidly all over the world. Severe hypoxemic respiratory failure from COVID-19 …

Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months,
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …

Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to
excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation …

Background Evidence supports an excess of deaths during the COVID-19 pandemic. We
report the incidence and mortality of thrombo-embolic events (TE) during the COVID-19 …

Background Venous thromboembolism (VTE) is a frequent complication in critically ill
patients with coronavirus disease 2019 (COVID-19) and is associated with mortality. Early …

May 4, 2020, there are> 1.2 million confirmed cases in the United States and> 66 000
deaths. Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and …

2. Methods This study followed the Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) reporting guideline (Supplementary file 1). Data were obtained …

Background The incidence of venous thromboembolic events (VTE) in patients with COVID-
19 is generally high but varies markedly. However, the relationship between anticoagulation …

Background Few data are available on the rate and characteristics of thromboembolic
complications in hospitalized patients with COVID-19. Methods We studied consecutive …